Heritage Florida Jewish News - Central Florida's Independent Jewish Voice

Women giving birth by Caesarean section could be the first to benefit from a revolutionary Israeli invention for closing surgical incisions without stitches or staples. The technique also promises to leave patients less prone to infection and scarring. BioWeld1, a unique trademarked product from Israeli startup IonMed, welds surgical incisions using cold plasma.

Plasma is a gas in which a certain proportion of the particles are ionized. It has been shown to offer manifold benefits including tissue welding, control of bleeding, enhancement of tissue repair, disinfection and destruction of cancer cells. However, plasma has enjoyed a limited role in surgery due to the high temperatures it creates and resulting harmful effects on body tissue. IonMed’s scientists found a way to make use of cold plasma as the power behind the BioWeld1.

The product provides a next-generation alternative to staples and stitches.

The procedure takes a few minutes, seals the area completely, leaves minimal scarring or painful stitches, and does not require complex training.

“No one has done this before—and more than that, the platform of cold plasma is a technology that is not available in medicine yet,” says Ronen Lam, IonMed’s co-founder and vice president for business development. “We will probably be the first,” he tells ISRAEL21c.

The company anticipates receiving the CE mark of approval in Europe by the end of the year. After closing its next financial round, IonMed would then look into beginning trials in Europe and in the United States toward getting approval of the U.S. Food and Drug Administration (FDA) and launching its next cold plasma-based product.

For full story visit Israel21c.org